This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.
Diabetes, obesity & metabolism, 23 Suppl 3, 5-29
Citation
Nauck, Michael A; Quast, Daniel R; Wefers, Jakob; Pfeiffer, Andreas F H. (2021). The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.. Diabetes, obesity & metabolism, 23 Suppl 3, 5-29. https://doi.org/10.1111/dom.14496